Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
A tool for prediction of risk of rehospitalisation and mortality in the hospitalised elderly: secondary analysis of clinical trial data
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Clinical pharmacogenomics and osteoporosis.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Clinical pharmacogenomics and osteoporosis.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm, UCR-Uppsala Clinical Research Center.
Show others and affiliations
2015 (English)In: BMJ Open, E-ISSN 2044-6055, Vol. 5, no 2, article id e007259Article in journal (Refereed) Published
Abstract [en]

Objectives: To construct and internally validate a risk score, the '80+ score', for revisits to hospital and mortality for older patients, incorporating aspects of pharmacotherapy. Our secondary aim was to compare the discriminatory ability of the score with that of three validated tools for measuring inappropriate prescribing: Screening Tool of Older Person's Prescriptions (STOPP), Screening Tool to Alert doctors to Right Treatment (START) and Medication Appropriateness Index (MAI). Setting: Two acute internal medicine wards at Uppsala University hospital. Patient data were used from a randomised controlled trial investigating the effects of a comprehensive clinical pharmacist intervention. Participants: Data from 368 patients, aged 80 years and older, admitted to one of the study wards. Primary outcome measure: Time to rehospitalisation or death during the year after discharge from hospital. Candidate variables were selected among a large number of clinical and drug-specific variables. After a selection process, a score for risk estimation was constructed. The 80+ score was internally validated, and the discriminatory ability of the score and of STOPP, START and MAI was assessed using C-statistics. Results: Seven variables were selected. Impaired renal function, pulmonary disease, malignant disease, living in a nursing home, being prescribed an opioid or being prescribed a drug for peptic ulcer or gastroesophageal reflux disease were associated with an increased risk, while being prescribed an antidepressant drug (tricyclic antidepressants not included) was linked to a lower risk of the outcome. These variables made up the components of the 80+ score. The C-statistics were 0.71 (80+), 0.57 (STOPP), 0.54 (START) and 0.63 (MAI). Conclusions: We developed and internally validated a score for prediction of risk of rehospitalisation and mortality in hospitalised older people. The score discriminated risk better than available tools for inappropriate prescribing. Pending external validation, this score can aid in clinical identification of high-risk patients and targeting of interventions.

Place, publisher, year, edition, pages
2015. Vol. 5, no 2, article id e007259
National Category
Other Medical Sciences
Identifiers
URN: urn:nbn:se:uu:diva-246233DOI: 10.1136/bmjopen-2014-007259ISI: 000363455400040OAI: oai:DiVA.org:uu-246233DiVA, id: diva2:792408
Available from: 2015-03-03 Created: 2015-03-03 Last updated: 2023-08-28Bibliographically approved

Open Access in DiVA

fulltext(1202 kB)564 downloads
File information
File name FULLTEXT01.pdfFile size 1202 kBChecksum SHA-512
de0244892dfdbd464cc2227a8885e40c172984f0412a7c48c48de6f22a04d5b8c1c2819acb7d561ec476359e4b0c70083893318cb110af80decabe8e0826e602
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Authority records

Alassaad, AnnaMelhus, HåkanHammarlund-Udenaes, MargaretaBertilsson, MariaSundström, Johan

Search in DiVA

By author/editor
Alassaad, AnnaMelhus, HåkanHammarlund-Udenaes, MargaretaBertilsson, MariaSundström, Johan
By organisation
Clinical pharmacogenomics and osteoporosisDepartment of Pharmaceutical BiosciencesUCR-Uppsala Clinical Research CenterCardiology
In the same journal
BMJ Open
Other Medical Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 564 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 1710 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf